What is Rinascera Therapeutics worth?
$5.0Mlast known valuation
Rinascera Therapeutics last raised $2.5M in its Seed Round (Sep 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Rinascera Therapeutics
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Sep 2025 | Seed Round | $2.5M | ▮ | ▮ |
How Rinascera Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Rinascera Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Rinascera Therapeutics worth?
- Rinascera Therapeutics's last known valuation is $5.0M.
- How much has Rinascera Therapeutics raised?
- Rinascera Therapeutics has raised $2.5M in total funding across 1 recorded rounds.
- When did Rinascera Therapeutics last raise?
- Rinascera Therapeutics last raised in Sep 2025 (Seed Round), raising $2.5M.